About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...

Innovative Pharmaceutical Initiative – iF!

iF! position on biological and biosimilar medicines

Therapy switch means a medical practice in which the physician decides to replace the product the patient is currently being treated with by another product. The practice in which a physician decides to switch between different biological molecules is not new.

Therapy switch means a medical practice in which the physician decides to replace the product the patient is currently being treated with by another product. The practice in which a physician decides to switch between different biological molecules is not new.

Therapy switch means a medical practice in which the physician decides to replace the product the patient is currently being treated with by another product. The practice in which a physician decides to switch between different biological molecules is not new. Typically, a switch is driven by a clinical decision to find an appropriate therapy for the patient due to insufficient efficacy and/or tolerability of the previous product.

Biological medicines, including biosimilar medicines, are medical products usually derived from proteins produced using living organisms. Biological medicines are generally larger and more complex than small‑molecule medicines, and the clinical response depends on multiple factors related to the patient, the disease, and the product, which are best assessed by the physician.

Published
4. August 2017.
Source
Category

Latest News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
01/2026
Interview with Javier Aracil Corma, General Manager of the AbbVie Adriatic and Hungary...
01/2026
Croatia at a crossroads – time for bold decisions in healthcare!...
02/2021
Advances in the research and development of therapeutic options witnessed in recent years...
02/2021
There are significant differences in treatment outcomes across European Union member states, and...
02/2021
Thanks to new knowledge and the discovery of new medicines that had previously...
Scroll to Top

About Us

Business Ethics

Strategic Projects

Initiatives

Useful Links

Members

News

02/2026
Interview with Schalk Opperman, GM/MD at Merck Croatia & Slovenia...
02/2026
Interview with Lana Kuzik Ileš, Country Manager, Bayer Croatia...
Start typing to search